Sign in
☰
People MPsHouse of LordsGovernmentOppositionPartiesCommittees Votes Commons votesLords votesVotes by issueTopicsStats & rankingsParliament in numbers Legislation BillsEarly day motionsPetitions Elections Election resultsConstituenciesWho is my MP? Scotland OverviewMSPsScottish GovernmentVotesBillsMotionsCommitteesConstituencies & regionsElections Search Sign in

Bill · started in the Commons

Pharmaceutical Labelling (Warning Of Cognitive Function Impairment) Bill

A Bill to make provision for a warning symbol to be prominently displayed on the packaging of pharmaceuticals which act on the brain and central nervous system so as to impair dangerously the consumer’s ability to carry out certainactivities; and for connected purposes.

In progress Current stage: 2nd reading (Commons)

The story so farThe Pharmaceutical Labelling (Warning Of Cognitive Function Impairment) Bill was introduced in the House of Commons on 26 January 2009 by Mr Andrew Dismore (Labour). It is now at second reading in the House of Commons. Second reading is the first debate on the overall principle of the bill; if the bill clears it, detailed committee scrutiny follows.

What the bill does

The Bill would make provision for a warning symbol to be prominently displayed on the packaging of specified psychoactive pharmaceuticals, which act on the brain and central nervous system and which can impair dangerously the consumer’s ability to carry out certain activities.

Progress through Parliament

  1. 1st reading Commons 26 Jan 2009
  2. 2nd reading Commons Current

Source: the official bill page. Last updated 9 Nov 2009.